Delivery Order 47QTCB22D0589-75F40125F80088

Award Date 7/1/25
Potential Completion Date 7/1/27
Potential Value $3.8M
Awardee
Agisol LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the U.S. Food and Drug Administration (FDA) to Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract is for $2,538,816.41 and provides office support services to the FDA's Office of Clinical Policy. The contract is a Delivery Order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and...
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business based in Marriottsville, Maryland. The contract, valued at $3,508,732.19, is for regulatory review systems analysis and sunset support services for the Center for Drug Evaluation and Research (CDER). The contract has no set-aside designation and is set to be completed by January 20, 2027. Agisol LLC holds an 8(a) STARS III Government-Wide...
This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services...
This is a sole source 8(a) set-aside federal contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small, minority-owned, woman-owned business. The contract is for $597,096.99 and provides process documentation and development services to the FDA's Center for Drug Evaluation and Research (CDER). The contract has a period of performance through August 21, 2028. Agisol LLC, a certified 8(a) program participant, is the prime contractor for this contract. The company...
This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including...
This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER),...
This is a labor-hour award made by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an 8(a) certified small disadvantaged business, to provide regulatory review of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) production support services for the Center for Drug Evaluation and Research (CDER). The contract, valued at $4,499,636.43, runs from the award date of February 4, 2024 through December 17, 2025. Agisol LLC has extensive experience supporting the FDA's...
The U.S. Food and Drug Administration (FDA) awarded a $1,189,125.49 time-and-materials contract to Agisol LLC, an SBA-certified 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), to streamline processes and enhance new drug review services. This contract was issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions. Agisol LLC specializes in providing IT services and solutions...
The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
The U.S. Food and Drug Administration (FDA) has awarded a $4,481,143.91 Delivery Order contract to Agisol LLC, an 8(a) certified small disadvantaged business, for CDER Streamline Process and Enhance Functions for New Drug Review. This is a Time and Materials contract awarded under the GSA Multiple Award Schedule (MAS) vehicle. Agisol LLC is a small IT services provider that specializes in supporting the FDA's regulatory review and research activities, including work on systems like the...

This is a Firm Fixed Price delivery order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business registered to receive federal contract awards since 2014. The objective of this order is to acquire expert consulting support and services to support the mission of the FDA's Office of Business Informatics (OBI). Agisol LLC, an SBA-certified 8(a) Program participant and Economically Disadvantaged Women-Owned Small Business (EDWOSB), will provide operational and release management support across core functional areas. The contract has a ceiling value of $3,778,152.50 and a period of performance ending on July 1, 2027. This contract is not set aside. Agisol LLC holds a position on the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions, which has enabled the company to secure significant task orders from the FDA for regulatory review systems support and process documentation services.

Generated 7/2/25, 11:03 PM